Mel DeCorby
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 6
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- George G. Zhanel (11 shared papers)Philippe Lagacé‐Wiens (8 shared papers)James A. Karlowsky (8 shared papers)Aleksandra Wierzbowski (6 shared papers)Kim Nichol (6 shared papers)Michael R. Mulvey (6 shared papers)Daryl J. Hoban (8 shared papers)Patricia J. Baudry (6 shared papers)
- Journals
- Diagnostic Microbiology and Infectious Disease (1 paper)Current Allergy and Asthma Reports (1 paper)Current Infectious Disease Reports (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Expert Review of Anti-infective Therapy (1 paper)
- Partner nations
- Canada
In The Last Decade
Mel DeCorby
11 papers receiving 390 citations
Peers
Comparison fields: 5 of 53
- Applied Microbiology and Biotechnology 73
- Molecular Medicine 185
- Clinical Biochemistry 61
- Critical Care and Intensive Care Medicine 37
- Infectious Diseases 112
Countries citing papers authored by Mel DeCorby
This map shows the geographic impact of Mel DeCorby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel DeCorby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel DeCorby more than expected).
Fields of papers citing papers by Mel DeCorby
This network shows the impact of papers produced by Mel DeCorby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel DeCorby. The network helps show where Mel DeCorby may publish in the future.
Co-authors
The 22 scholars most cited alongside Mel DeCorby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 215 | |
| 2 | 2008 | 51 | |
| 3 | 2008 | 46 | |
| 4 | 2008 | 25 | |
| 5 | 2006 | 19 | |
| 6 | 2006 | 18 | |
| 7 | 2005 | 17 | |
| 8 | 2009 | 16 | |
| 9 | 2009 | 2 | |
| 10 | 2009 | 2 | |
| 11 | 2009 | 1 |
About Mel DeCorby
Mel DeCorby is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 11 papers that have together received 412 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Urinary Tract Infections Management (2 papers), Pneumonia and Respiratory Infections (2 papers) and Biochemical and Structural Characterization (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (73 citations), Molecular Medicine (185 citations), Clinical Biochemistry (61 citations), Critical Care and Intensive Care Medicine (37 citations) and Infectious Diseases (112 citations). Mel DeCorby has collaborated with scholars based in Canada. Frequent co-authors include George G. Zhanel, Philippe Lagacé‐Wiens, James A. Karlowsky, Aleksandra Wierzbowski, Kim Nichol, Michael R. Mulvey, Daryl J. Hoban, Patricia J. Baudry, Andrew Walkty and Melissa McCracken. Their work appears in journals such as Diagnostic Microbiology and Infectious Disease, Current Allergy and Asthma Reports, Current Infectious Disease Reports, Antimicrobial Agents and Chemotherapy and Expert Review of Anti-infective Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.